News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
252,565 Results
Type
Article (5898)
Company Profile (28)
Press Release (246639)
Multimedia
Podcasts (2)
Webinars (5)
Section
Business (87688)
Career Advice (472)
Deals (16484)
Drug Delivery (9)
Drug Development (21242)
Employer Resources (32)
FDA (4052)
Job Trends (4556)
News (129794)
Policy (8423)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (337)
Accelerated approval (8)
Adcomms (4)
Allergies (15)
Alliances (16224)
ALS (42)
Alzheimer's disease (378)
Antibody-drug conjugate (ADC) (48)
Approvals (4163)
Artificial intelligence (95)
Autoimmune disease (32)
Automation (5)
Bankruptcy (107)
Best Places to Work (3390)
Biosimilars (33)
Biotechnology (30)
Bladder cancer (39)
Brain cancer (10)
Breast cancer (144)
Cancer (1026)
Cardiovascular disease (68)
Career advice (404)
Career pathing (3)
CAR-T (67)
CDC (2)
Cell therapy (178)
Cervical cancer (5)
Clinical research (18516)
Collaboration (393)
Compensation (386)
Complete response letters (9)
COVID-19 (461)
CRISPR (13)
C-suite (358)
Cystic fibrosis (30)
Data (1478)
Denatured (1)
Depression (24)
Diabetes (86)
Diagnostics (2337)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (14)
Drug discovery (48)
Drug pricing (14)
Drug shortages (2)
Duchenne muscular dystrophy (39)
Earnings (44779)
Editorial (5)
Employer branding (6)
Employer resources (34)
Events (41990)
Executive appointments (448)
FDA (4846)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (399)
Gene editing (25)
Generative AI (5)
Gene therapy (102)
GLP-1 (164)
Government (519)
Guidances (204)
Healthcare (5578)
HIV (10)
Huntington's disease (5)
IgA nephropathy (18)
Immunology and inflammation (41)
Immuno-oncology (8)
Indications (16)
Infectious disease (493)
Inflammatory bowel disease (36)
Inflation Reduction Act (3)
Influenza (6)
Intellectual property (37)
Interviews (57)
IPO (8473)
IRA (3)
Job creations (1259)
Job search strategy (366)
JPM (4)
Kidney cancer (10)
Labor market (10)
Layoffs (113)
Leadership (5)
Legal (2679)
Liver cancer (21)
Longevity (4)
Lung cancer (106)
Lymphoma (75)
Machine learning (4)
Management (11)
Manufacturing (155)
MASH (50)
Medical device (4372)
Medtech (4385)
Mergers & acquisitions (8474)
Metabolic disorders (227)
Multiple sclerosis (22)
NASH (6)
Neurodegenerative disease (65)
Neuropsychiatric disorders (14)
Neuroscience (654)
NextGen: Class of 2026 (1792)
Non-profit (794)
Now hiring (5)
Obesity (90)
Opinion (33)
Ovarian cancer (26)
Pain (33)
Pancreatic cancer (51)
Parkinson's disease (52)
Partnered (12)
Patents (67)
Patient recruitment (106)
Peanut (6)
People (27128)
Pharmaceutical (11)
Pharmacy benefit managers (2)
Phase 1 (5502)
Phase 2 (8136)
Phase 3 (6397)
Pipeline (2052)
Policy (17)
Postmarket research (658)
Preclinical (2176)
Press Release (67)
Prostate cancer (63)
Psychedelics (5)
Radiopharmaceuticals (126)
Rare diseases (190)
Real estate (2025)
Recruiting (9)
Regulatory (6097)
Reports (18)
Research institute (359)
Resumes & cover letters (69)
Rett syndrome (19)
RNA editing (4)
RSV (2)
Schizophrenia (57)
Series A (58)
Series B (56)
Service/supplier (2)
Sickle cell disease (11)
Special edition (1)
Spinal muscular atrophy (35)
Sponsored (6)
Startups (1132)
State (1)
Stomach cancer (1)
Supply chain (17)
Tariffs (7)
The Weekly (1)
Vaccines (107)
Venture capital (10)
Weight loss (31)
Women's health (7)
Date
Today (14)
Last 7 days (171)
Last 30 days (596)
Last 365 days (9916)
2026 (894)
2025 (10079)
2024 (12206)
2023 (14505)
2022 (20417)
2021 (21845)
2020 (19698)
2019 (14289)
2018 (11001)
2017 (10866)
2016 (9994)
2015 (13151)
2014 (10360)
2013 (8347)
2012 (9039)
2011 (9443)
2010 (9255)
Location
Africa (201)
Alabama (20)
Alaska (2)
Arizona (83)
Arkansas (1)
Asia (12514)
Australia (1761)
California (3673)
Canada (1755)
China (173)
Colorado (152)
Connecticut (168)
Delaware (76)
Europe (26906)
Florida (565)
Georgia (76)
Idaho (24)
Illinois (168)
India (15)
Indiana (139)
Iowa (9)
Japan (178)
Kansas (37)
Kentucky (18)
Louisiana (8)
Maine (51)
Maryland (359)
Massachusetts (2909)
Michigan (143)
Minnesota (232)
Mississippi (1)
Missouri (31)
Montana (17)
Nebraska (14)
Nevada (53)
New Hampshire (27)
New Jersey (1233)
New Mexico (8)
New York (925)
North Carolina (518)
North Dakota (4)
Northern California (1917)
Ohio (117)
Oklahoma (8)
Oregon (6)
Pennsylvania (689)
Puerto Rico (2)
Rhode Island (19)
South America (311)
South Carolina (17)
Southern California (1345)
Tennessee (71)
Texas (563)
United States (13336)
Utah (114)
Virginia (85)
Washington D.C. (17)
Washington State (307)
West Virginia (2)
Wisconsin (71)
Wyoming (2)
252,565 Results for "nevro corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients
February 6, 2025
·
8 min read
Biotech Bay
Nevro to Present at Truist Securities MedTech Conference
Nevro Corp. announced that members of its management team will participate in a “fireside chat” session at the Truist Securities MedTech Conference on Tuesday, June 18, 2024, beginning at approximately 8:40 am EDT.
June 11, 2024
·
2 min read
Deals
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 - June 28, 2024
Nevro Corp. announced that on June 7, 2024, the Compensation Committee of the Company’s Board of Directors granted inducement restricted stock unit awards covering 56,692 shares of Nevro’s common stock to 17 new non-executive employees to induce them to accept employment with Nevro.
June 28, 2024
·
2 min read
Biotech Bay
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08
Nevro Corp. announced that on May 7, 2024, the Compensation Committee of the Company’s Board of Directors granted inducement restricted stock unit awards covering 59,460 shares of Nevro’s common stock to twenty-six new non-executive employees to induce them to accept employment with Nevro.
May 24, 2024
·
2 min read
Business
Nevro Reports First-Quarter 2024 Financial Results
Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today reported its first quarter 2024 financial results.
May 7, 2024
·
19 min read
Biotech Bay
Nevro to Present at BofA Securities 2024 Healthcare Conference
Nevro Corp., a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, announced that members of its management team will participate in the BofA Securities 2024 Healthcare Conference on Tuesday, May 14, 2024.
May 9, 2024
·
2 min read
Business
Nevro Enters Into Cooperation Agreement With Engaged Capital
Nevro Corp. announced that it has entered into a Cooperation Agreement with Engaged Capital, LLC, pursuant to which Kirt P. Karros has been appointed to Nevro’s Board of Directors as well as the Audit Committee of the Board effective February 20, 2024.
February 21, 2024
·
4 min read
Press Releases
Profound Medical Corp. Announces Closing of Private Placement
December 30, 2025
·
5 min read
Press Releases
Anteris Technologies Global Corp. Announces Pricing of $200 Million Public Offering
January 21, 2026
·
7 min read
Press Releases
Scryb Inc. Provides Early Warning Update on Holdings in Cybeats Technologies Corp.
January 15, 2026
·
5 min read
1 of 25,257
Next
